Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (Q34673134)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
scientific article

    Statements

    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. (English)
    Christoph Wanner
    David Fitchett
    Erich Bluhmki
    Stefan Hantel
    Michaela Mattheus
    Theresa Devins
    Hans J Woerle
    Uli C Broedl
    EMPA-REG OUTCOME Investigators
    17 September 2015
    2117-2128

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit